Common Contracts

1 similar null contracts

FOURTH SUPPLEMENTAL DEBENTURE INDENTURE
Ontario • February 13th, 2019
Jurisdiction
Filed
February 13th, 2019
WHEREAS the Company, MPX Bioceutical Corporation (“MPX Corp”) (amalgamation predecessor to the Parent) and the Trustee entered into an indenture dated May 25, 2018 (the “Base Indenture”), providing for the issuance of convertible debentures (the “Debentures”) in the aggregate principal amount of US$49,257,572.60;